Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

ACN Newswire press release news - Recent Press Releases

older | 1 | .... | 301 | 302 | (Page 303) | 304 | 305 | .... | 320 | newer

    0 0

    Alltronics launches the second generation portable photocatalyst deodoriser at 2018 Hong Kong Electronics Fair
    Mr. Lam Yin Kee, Chairman of Alltronics and Ms. Ivy Lam, Investor Relationship Manager demonstrated the Second Generation Portable Photocatalyst Deodoriser at 2018 Hong Kong Electronics Fair
    Further Demonstrates its Outstanding R&D and Production Capabilities

    HONG KONG, Oct 15, 2018 - (ACN Newswire) - Alltronics Holdings Limited ("Alltronics" or the "Group") (Stock code: 833), a leading electronic products manufacturer, a provider of energy-saving business solutions and property rental services, launched the new photocatalyst deodoriser at 2018 Hong Kong Electronics Fair , which further demonstrates its outstanding R&D and production capabilities.

    The portable photocatalyst deodoriser debuting at the exhibition uses photocatalytic technology, i e, combining UV sterilisation and chemical technology, which not only can neutralise odour indoor quickly and effectively, but also kills all types of bacteria, viruses, fungus and remove air pollutants, including methanol. Led by Dr. Alan Lee, who has over 30 years experience in the photochemical field, the Group continues to make technological breakthroughs. The Group believes that the photocatalyst deodoriser business will generate a new income stream, thus benefitting itself and shareholders as well.

    Meanwhile, the Group has set up new production facilities at Yichun, Jiangxi in China for its electronic products and components so as to expand its overall production capacity to cope with the increasing demand from customers and for production of newly-launched products. Management believes that the demand for new products, including new models of walkie-talkies, electronic educational toys and photolysis deodoriser, will provide strong momentum for the growth in revenue in the long run.

    About Alltronics Holdings Limited (Stock code: 833)
    Alltronics Holdings Limited is mainly engaged in the design and manufacture of a wide range of electronics products with quality and style, supplying biodiesel products as well as the provision of energy-saving business solutions and property rental services. Besides, the Company is in the process of diversifying its business into manufacturing patented Wi-Fi Products, medical equipment and printers. The Company is a constituent stock of the Morgan Stanley Capital International ("MSCI") Hong Kong Micro Cap Index. For more information, please visit http://www.alltronics.com.hk/.

    Media enquiries
    Strategic Financial Relations Limited
    Vicky Lee Tel.: +852 2864 4834 Email : vicky.lee@sprg.com.hk
    Ka Wai Li Tel.: +852 2864 4855 Email : kawai.li@sprg.com.hk
    Boni Liu Tel.: +852 2864 4870 Email : boni.liu@sprg.com.hk
    Fax: +852 2527 1196
    Website: www.sprg.com.hk


     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    BOSTON, Oct 15, 2018 - (ACN Newswire) - Catastrophe risk modeling firm AIR Worldwide estimates that industry insured losses resulting from Hurricane Michael's winds and storm surge will range from USD 6 billion to USD 10 billion. AIR Worldwide is a Verisk (Nasdaq:VRSK) business.

    "Fueled by unseasonably high 84-degree sea surface temperatures in the Gulf of Mexico and unhindered by any prior landfall, Hurricane Michael rapidly intensified shortly before making landfall at close to Category 5 intensity," said Dr. Peter Sousounis, vice president and director of meteorology, AIR Worldwide. "It struck near Mexico Beach in the Florida Panhandle on the afternoon of Wednesday, October 10, with maximum sustained winds of 155 mph (250 km/h). The minimum central pressure at landfall - a key measure of hurricane strength - was 919 mb, the third lowest on record for a U.S. hurricane. Michael is the most powerful hurricane to have come ashore in the Florida Panhandle since the first records were kept in 1851."

    At landfall hurricane-force winds extended outward up to 45 miles (75 km) from the center of the system and tropical storm-force winds extended outward up to 175 miles (280 km). It lost strength as it progressed across the Florida Panhandle and into southeastern Alabama and southwestern Georgia, weakening to a tropical storm.

    Dr. Sousounis continued, "Most wind damage was confined to the Florida Panhandle and southern Georgia, although some local wind-related damage such as downed trees and power lines occurred farther north along the track into the Carolinas. Since Michael was a fairly rapidly moving storm, precipitation accumulation was far less than for Florence, although some of the areas previously flooded by Florence were already saturated. Forecasts of around 4 to 8 inches of rain along the track through the southeastern U.S. were accurate, and these rains triggered some local flash flooding."

    While there are no depth measurements in Mexico Beach currently available, this community was in the right eyewall of Michael where storm surge is typically the highest. Catastrophic storm surge damage in Mexico Beach virtually obliterated this community. Video taken during Hurricane Michael in Mexico Beach shows surge that has reached the undersides of the rooflines there. Given that typical ceiling height is 8 to 9 feet, it is safe to assume that surge reached at least 8 feet above ground and potentially more than 10 feet. In addition, a National Ocean Service water level station at Apalachicola reported around 8.5 feet of surge above mean sea level shortly after landfall.

    At Tyndall Air Force Base, which is west of Mexico Beach, a wind gust of 129 mph was measured. The base saw significant damage to structures, aircraft, and vehicles, including an aircraft hangar that lost its entire roof, revealing damaged fighter jets inside.

    The residential community of Mexico Beach suffered the brunt of Michael's fury and the majority of structures in that town were destroyed, primarily by storm surge. While Mexico Beach's year-round population is 2,000, it is a popular tourist destination for sports-fishing. Panama City - and the surrounding areas of Lynn Haven and Callaway, which are located approximately 20 miles to the west of Mexico Beach - was also hit hard by Hurricane Michael. Damage to single-family and manufactured homes ranged from minor roof damage to complete destruction. Heavy damage was also reported for small commercial structures, hotels, hospitals, and schools.

    Based on initial damage reports, Panama City Beach, which is located right on the Gulf, seemed to fare slightly better than the more inland Panama City; however, heavy damage was also reported in Panama City Beach.

    Farther inland, the City of Tallahassee, the state capital, reported a number of trees down, but the majority of the trees fell in yards or on roads with relatively few reports of structural damage caused by tree fall.

    Initial reports indicate little significant structural damage in Georgia and the majority of initial reports coming from Alabama, South Carolina, North Carolina, and Virginia indicated downed trees in roadways but very little structural damage.

    AIR's modeled insured loss estimates include:

    - Insured physical damage to property (residential, commercial, industrial, auto), both structures and their contents from winds, wind-borne debris and storm surge
    - Additional living expenses (ALE) for residential claims and business interruption losses for commercial claims
    - For the automobile line, estimates reflect AIR's view that insurers will pay for the storm surge damage

    AIR's modeled insured loss estimates do not include:

    - Precipitation-induced flooding
    - Losses paid out by the National Flood Insurance Program
    - Losses to inland marine, marine cargo and hull, and pleasure boats
    - Losses to uninsured properties
    - Losses to infrastructure
    - Losses from extra-contractual obligations
    - Losses from hazardous waste cleanup, vandalism, or civil commotion, whether directly or indirectly caused by the event
    - Losses resulting from the compromise of existing defenses (e.g., natural and man-made levees)
    - Other non-modeled losses, including those resulting from tornadoes spawned by the storm
    - Losses for U.S. offshore assets and non-U.S. property

    About AIR Worldwide

    AIR Worldwide (AIR) provides risk modeling solutions that make individuals, businesses, and society more resilient to extreme events. In 1987, AIR Worldwide founded the catastrophe modeling industry and today models the risk from natural catastrophes, terrorism, pandemics, casualty catastrophes, and cyber incidents. Insurance, reinsurance, financial, corporate, and government clients rely on AIR's advanced science, software, and consulting services for catastrophe risk management, insurance-linked securities, longevity modeling, site-specific engineering analyses, and agricultural risk management. AIR Worldwide, a Verisk (Nasdaq:VRSK) business, is headquartered in Boston, with additional offices in North America, Europe, and Asia. For more information, please visit www.air-worldwide.com.

    For more information, contact:
    Kevin Long
    AIR Worldwide
    617-267-6645
    klong@air-worldwide.com

    ###

    This announcement is distributed by West Corporation on behalf of West Corporation clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: AIR Worldwide via Globenewswire

     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    Paris, Amsterdam, Oct 16, 2018 - (ACN Newswire) - On October 15, 2018, Unibail-Rodamco-Westfield entered into an agreement with Singapore's sovereign wealth fund GIC for the sale of Tour Ariane in La Defense. The net disposal price of EUR464.9 Mn represents a premium to the latest unaffected book value.

    This transaction is subject to standard conditions precedent and is expected to close by year-end.

    Tour Ariane is an office building with a GLA of over 64,500 m2 located in the heart of the La Defense business district (Paris region).

    The transaction is part of the EUR3 Bn European disposal programme to be executed over the next several years previously announced by Unibail-Rodamco-Westfield. More than 55% of this programme has been agreed or completed since June 30, 2018.

    For further information, please contact:

    Investor Relations
    Samuel Warwood
    Maarten Otte
    +33 1 76 77 58 02
    Maarten.otte@urw.com

    Media Relations
    Tiphaine Bannelier-Suderie
    D: +33 1 76 77 57 94
    Tiphaine.Bannelier-Suderie@urw.com

    About Unibail-Rodamco-Westfield

    Unibail-Rodamco-Westfield is the premier global developer and operator of flagship shopping destinations. With a portfolio valued at EUR63.7 Bn as at June 30, 2018, of which 86% in retail, 8% in offices, 5% in convention & exhibition venues and 1% in services, the Group owns and operates 102 shopping centres, including 56 flagships in the most dynamic cities in Europe and the United States. Its centres welcome 1.2 billion visits per year. Present on 2 continents and in 13 countries, Unibail-Rodamco-Westfield provides a unique platform for retailers and brand events, and offers an exceptional and constantly renewed experience for customers.

    With the support of its 3,700 professionals and an unparalleled track-record and know-how, Unibail-Rodamco-Westfield is ideally positioned to generate superior value and develop world-class projects. The Group has the largest development pipeline in the industry, worth EUR12.5 Bn.

    Unibail-Rodamco-Westfield distinguishes itself by its Better Places 2030 agenda, that sets its ambition to create better places that respect the highest environmental standards and contribute to better cities.

    Unibail-Rodamco-Westfield stapled shares are listed on Euronext Amsterdam and Euronext Paris (Euronext ticker: URW), with a secondary listing in Australia through Chess Depositary Interests. The Group benefits from an A rating from Standard & Poor's and from an A2 rating from Moody's.

    For more information, please visit www.urw.com
    Visit our Media Library at https://mediacentre.urw.com

    20181015 URW PR - Signing Tour Ariane EN: http://hugin.info/136618/R/2220420/868932.pdf

     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    Signing Ceremony
    - MOU Signed with New South Wales Government -

    - Solutions utilizing MHI Group product technologies and services to support large-scale urban development project.
    - High quality infrastructure to be provided for planned Sydney airport and surrounding areas.

    TOKYO, Oct 16, 2018 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) yesterday concluded and signed a Memorandum of Understanding (MOU) with the Government of New South Wales in Australia to provide a range of solutions for energy management and other technologies utilizing MHI's products and services, as part of the comprehensive development plan for the Western Sydney region being undertaken by the state.

    The MOU was signed by New South Wales Premier Gladys Berejiklian, and for MHI by Ken Kawai, Chief Regional Officer for Asia Pacific and India. The ceremony was attended by ambassadors from both countries, and other dignitaries. The principal objective of the agreement is to provide the New South Wales Government, in conjunction with the Australian Federal Government and eight municipalities in the Western Sydney region, with energy management solutions and the high quality social infrastructure that is a specialty of MHI Group, to support the Second Sydney Airport, scheduled for completion in 2026, and the surrounding area.

    The New South Wales Government, which is coordinating the infrastructure development for the region, formulated a plan to decentralize city functions by creating several central business districts (CBDs) in the Sydney metropolitan area. In addition to the Sydney CBDs, the government has begun a second CBD development program by inducing state government agencies to relocate to suburban areas, with participation from leading companies, universities, and research institutions.

    MHI Group is proposing an environment-conscious style of urban development that makes full use of advanced technologies and related systems, such as optimal energy management methods for the urban development of Western Sydney, as well as industrial parks and the airport. The proposal makes proactive use of the results from smart community demonstration projects MHI Group undertook for the vicinity of Kyoto Prefecture, and other projects outside Japan.

    MHI Group, by creating new business models utilizing advanced energy-saving and low-carbon technologies, is contributing to the further economic development of New South Wales.

    About Mitsubishi Heavy Industries, Ltd.

    Mitsubishi Heavy Industries (MHI) Group is one of the world's leading industrial firms. For more than 130 years, we have channeled big thinking into solutions that move the world forward - advancing the lives of everyone who shares our planet. We deliver innovative and integrated solutions across a wide range of industries, covering land, sea, sky and even space. MHI Group employs 80,000 people across 400 locations, operating in three business domains: "Power Systems," "Industry & Infrastructure," "Aircraft, Defense & Space." We have a consolidated revenue of around 40 billion U.S. Dollars. We aim to contribute to environmental sustainability while achieving global growth, using our leading-edge technologies. By bringing people and ideas together as one, we continue to pave the way to a future of shared success.

    For more information, please visit MHI's website: https://www.mhi.com
    For Technology, Trends and Tangents, visit MHI's new online media SPECTRA: https://spectra.mhi.com

    Contact:
    Corporate Communication Department Mitsubishi Heavy Industries, Ltd. Email: mediacontact_global@mhi.co.jp Tel: +81-(0)3-6716-2168 Fax: +81-(0)3-6716-5860

    Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com

    0 0

    NAM A JCB Platinum Credit Card
    NAM A JCB Standard Credit Card
    Ho Chi Minh and Tokyo, Oct 16, 2018 - (ACN Newswire) - Nam A Commercial Joint Stock Bank (Nam A Bank), a major commercial bank in Vietnam, and JCB International Co. Ltd. (JCBI), the international operations subsidiary of JCB Co., Ltd., today announced the launch Nam A Bank - JCB Credit Card in Vietnam.

    The holders of Nam A Bank - JCB Card can access the JCB acceptance network with about 30 million merchants in the world, and enjoy a lot of benefits provided by Nam A Bank, special privileges at selected merchants, and customer service at JCB Plaza, an overseas service counter.

    Moreover, Platinum Credit Card members are entitled to a number of other privileges such as access to over 73 airport lounges in Japan, China, Hong Kong, Singapore, Korea, Thailand and Vietnam; and 24/7 global support through a free hotline when booking car rental, hotel, restaurant, and golf in Japan.

    In addition, Nam A Bank offers free annual fee for the first year of the JCB Credit Card. From the launching date, Nam A Bank is also implementing many promotion programs, such as offering gifts, cash back, rewards, and interest discounts for payment in installments.

    About Nam A Bank

    Nam A Commercial Joint Stock Bank (Nam A Bank) was officially established on 21 October, 1992 as one of the first commercial joint stock banks established after the restructure regulation in Vietnam when the economy was reformed. After 25 years of operation, Nam A Bank's facilities and technology have been growing faster. Compared to the beginning with only three branches and nearly 50 employees with charter capital of USD 200,000, now Nam A Bank has expanded its network to 69 transaction points across the country, and the charter capital increased more than 600 times and the number of employees increased 30 times. The sales points of Nam A Bank cover major economic centers such as Ho Chi Minh City, Ha Noi, Da Nang, Nha Trang, Binh Duong, Can Tho, Long An, Vung Tau, Dong Nai, and Daklak.

    The current goal of Nam A Bank is to become one of Vietnam's most modern banks with stable, safe and effective development and become one of the leading commercial banks in Vietnam. Currently, Nam A Bank possesses the financial capacity, advanced technology and flexible services which can satisfy the demands of customers from various sectors, including individuals, corporations and investors. The bank has standardized its branch model and been creating professional and friendly standards for its customer service to realize its mission "Best in appearance - best in performance". For these activities, Nam A Bank has received many awards, domestic prizes and many international honors, such as "Best Customer Service Retail Bank Vietnam 2017", "ASEAN well-known brand". With a recent burst of growth, the bank has been able to build momentum and lay the foundation to rise to new heights. See www.namabank.com.vn.

    About JCB

    JCB is a major global payment brand and a leading payment card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase merchant coverage and card member base. As a comprehensive payment solution provider, JCB commits to provide responsive and high-quality service and products to all customers worldwide. For more information, please visit: www.global.jcb/en/

    Contact
    Kumiko Kida
    JCB Co., Ltd.
    Corporate Communications
    Tel: +81-3-5778-8353
    Email: jcb-pr@info.jcb.co.jp

     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    Average media allocation across WARC case studies by year chart
    WARC releases Media Allocation Benchmarks report

    LONDON, Oct 16, 2018 - (ACN Newswire) - WARC, the global authority on advertising and media effectiveness, has today released the latest edition of its Media Allocation Benchmark report, identifying the typical budget split of highly successful campaigns.

    Using its database of effective advertising campaigns, WARC has analysed close to 840 case studies between 2009 and 2017 that contain budget and media allocation information for TV, digital, print, out of home/experiential and other media.

    Some key findings included in the report are:

    - Successful brands have spent an average of 69% of their budgets on television and digital channels combined over the 2013 - 2017 period.

    - The biggest determinant of media allocation is the size of the budget. Successful, prize-winning low-budget campaigns are highly digital-focused. At high budget levels, TV takes up more than 60% of a prize-winning brand's advertising investment.

    - Media allocation varies by sector. Categories with low budgets, such as government and not-for-profit, are highly digital-led, as are transport and tourism; a category where consumers increasingly purchase online.

    - The food category has the most concentrated media investment profile. Prize-winning food campaigns allocated 81% of their budgets to TV and digital combined.

    Commenting on the findings in the report, Amy Rodgers, Research Editor, WARC, says: "Gaining the right balance of TV, which delivers reach, and digital, which supplements reach and aids activation, is a critical component of media allocation. The findings suggest that, when extra budget is available, it is often invested in TV."

    A sample of WARC's Media Allocation Benchmarks report is available to download on https://content.warc.com/read-media-allocation-benchmarks-report-2018-sample. The report in full is available to WARC subscribers on https://www.warc.com/content/article/Media_allocation_report/110231.


    About WARC

    - Your global authority on advertising and media effectiveness

    warc.com is an online service offering advertising best practice, evidence, insights and data from the world's leading brands. WARC helps clients grow their businesses by using proven approaches to maximise advertising effectiveness. WARC's clients include the world's largest advertising and media agencies, research companies, advertisers, market analysts and academics.

    WARC runs two global and two regional case study competitions: WARC Awards, WARC Media Awards, WARC Prize for Asian Strategy and WARC Prize for MENA Strategy.

    WARC publishes three global rankings of advertising excellence: Gunn 100 (creativity), WARC 100 (effectiveness), Gunn Media 100 (media innovation) and publishes leading journals including Admap, Market Leader, the Journal of Advertising Research and the International Journal of the Market Research Society. In addition to its own content, WARC features advertising case studies and best practices from more than 50 respected industry sources, including ARF, Effies, Cannes Lions, ESOMAR and IPA.

    Founded in 1985, WARC has offices in the UK, U.S. and Singapore. In June 2018 WARC was acquired by Ascential plc, the global specialist information company.

    Contact:
    Amanda Benfell PR Manager +44 20 7467 8125 amanda.benfell@warc.com

    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    Image 1 - Partial View of Area A
    Image 2 - Oxidation Blanket Vectorization
    Image 3 - Preliminary Model
    Image 4 - Mineralization Vectorization
    Vancouver, BC, Oct 16, 2018 - (ACN Newswire) - Lucky Minerals Inc. (TSX.V: LKY) (OTCPK: LKMNF) (FRA: 8LM) ("Lucky" or the "Company") is pleased to announce the results of a geological reconnaissance mapping survey conducted on its Fortuna Project located approximately 60 km south-east of Town of Cuenca, Ecuador. Prospecting and mapping were undertaken based on prior structural and enhanced alteration mapping studies using satellite imagery which were conducted in May/June 2018. Results from these studies led to the identification of 4 high prospectivity areas (A to D) covering 8 km2 in the Fortuna 3 concession.

    Image 1 - Partial View of Area A
    https://www.acnnewswire.com/topimg/Low_LuckyMinerals1810161.jpg

    Subsequent prospecting and mapping of Area A (2 km2) (Image 1) resulted in the discovery of two porphyry systems with approximate dimensions of 1.2 km on strike by 300m wide. A pluri-kilometric oxidation blanket composed of silica, limonite, jarosite and hematite surrounds the two porphyry systems.

    Image 2 - Oxidation Blanket Vectorization
    https://www.acnnewswire.com/topimg/Low_LuckyMinerals1810162.jpg

    Preliminary assessment of these two porphyry systems using major elements calculations is confirming field observations with an extensive potassic signature enrichment including an outer shell of pyrite mineralization typical of phyllic alteration that has been traced for more than 300m. Lucky's exploration team believes that these two porphyry systems may in fact form one single doughnut shaped body measuring approximately 2km in diameter.

    Image 3 - Preliminary Model
    https://www.acnnewswire.com/topimg/Low_LuckyMinerals1810163.jpg

    Saw sampling over the area outlined quartz monzonite rocks with pyrite and oxidized pyrite being the dominant sulphide mineral along with minor Chalcopyrite, Chalcosine, Molybdenite and Malachite (Oxide). 176 samples were sent to MS Analytical lab- oratory including 15 control samples for major oxides and ICP multi-element as- says; multi-elements results are pending.

    Image 4 - Mineralization Vectorization
    https://www.acnnewswire.com/topimg/Low_LuckyMinerals1810164.jpg

    Next Steps

    Lucky's immediate next steps to advance exploration on the property will be an airborne magnetics combined with radiometry survey with 3D inversion, improving the existing dirt road and trails to an all-weather 14 km gravel road, to be followed by an aggressive grid-style comprehensive sampling program along the two identified porphyry systems on Fortuna 3 as well as regional prospecting on the 40 km major regional NNE structure and other major regional NNE trending structures observed on the property. This may be followed by a drilling program in 2019. Fortuna 3 is one of 12 contiguous concessions which make up the Fortuna Property which has seen virtually no exploration and where considerable potential exists for finding significant porphyry and epithermal Cu-Au mineralization. It should be noted that no field work has been undertaken yet by Lucky and limited historical work was performed on the remaining 11 Fortuna concessions.

    Quality control

    Rock samples on the project were assayed by standard 30 grams fire-assaying with AA finish for gold, four acid ICP-OES for multi-elements (including Cu and Mo) and XRF for major elements (oxides) at MS Analytical in Vancouver, BC. Ex- ploration program design and interpretation of results is performed by a qualified person (QP) employing a Quality Assurance/Quality Control program consistent with industry best practices, including the use of standards at every 10 samples.

    Lucky is very pleased by the results of this summer 2018 reconnaissance exploration program and will continue to characterize in more details the two identified porphyry systems and aggressively exploring and prospecting other targets on Fortuna 3 as well as on the 11 remaining concessions of its Fortuna Project.

    About Lucky

    An exploration and development company targeting large-scale mineral systems in proven districts with the potential to host world class deposits.

    The Fortuna Project

    Lucky Minerals holds a 100% interest in Fortuna, a 550 km2 property in the heart of a proven and highly mineralized mineral district in Ecuador but which has seen only limited exploration and has never been drilled.

    Evidence of significant hydrothermal alteration & breccias, geochemical anomalies and placer mining supports potential for Cu/Au porphyry systems and epithermal Au deposits similar to numerous multi-million-ounce Au and bulk tonnage Cu deposits ~40km away.

    The Emigrant Creek Project

    Covers a 15 km2 area in an intensely altered and mineralized porphyry copper- gold-molybdenum system in southern Montana.

    Nine highly mineralized breccia-pipes and two porphyry targets are known to exist within the company's claims and have been variously explored by drilling, induced polarization geophysical surveys, rock chip sampling and geologic & alteration mapping.

    This press release has been prepared by Alain Moreau, P.Geo., VP-Exploration at Lucky Minerals Inc., a "qualified person" as defined by NI 43-101 instrument. For further information, please consult Lucky's website or contact:

    ON BEHALF OF THE BOARD
    John Mears
    Chief Executive Officer

    Further information regarding can be found on SEDAR at www.SEDAR.com.
    Tel.: 866 924-6484 Website: www.luckyminerals.com Email: info@luckyminerals.com

    Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    This press release may contain forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to vary materially from targeted results. Such risks and uncertainties include those described in Lucky's periodic reports including the annual report or in the filings made by Lucky from time to time with securities regulatory authorities.

    We seek safe harbor.

     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    TOKYO, Oct 16, 2018 - (JCN Newswire) - GAC Mitsubishi Motors is to start production of the all-new Eupheme EV Electric Vehicle SUV in China.

    GAC Mitsubishi Motors (GMMC) is a joint venture between the Mitsubishi Motors Corporation, Guangzhou Automobile Group (GAC) and the Mitsubishi Corporation. The Eupheme EV was designed by GAC and is produced by GMMC in Changsha, Hunan.

    The new model supports both Mitsubishi Motors and GAC's strategic growth goals, boosts development of an advanced automotive industry and will help rapid adoption of "new energy vehicle" (NEV)(1) technologies in the world's largest vehicle market.

    Twelve key cities will serve as the initial release markets for the Eupheme EV in China, including Beijing, Changsha, Guangzhou, Shenzhen, Hangzhou and Tianjin, with additional locations to be introduced across the country this year.

    Eupheme EV has a cruise distance of 410 km (the fuel consumption measurement in China), and combines the powerful torque of electric vehicle with the comfort and interior space of SUV, It will be priced from 135,800 RMB(2) (approximately $20,000) as an advanced and environmentally friendly SUV for Chinese customers.

    Commenting on the company's ambitions in China, Mitsubishi Motors Chief Executive Officer Osamu Masuko stated "The launch of Eupheme EV follows the Eupheme Plug-in Hybrid Electric (PHEV) SUV to market and is an important milestone for GMMC. It demonstrates the critical role that EV technology will play in meeting Chinese consumers' needs and contributes to the automotive industry in China. China is one of our most important markets and we look forward to greatly expanding our position in the country during our DRIVE FOR GROWTH plan."

    As a strategic partnership, sales and production platform in China, GMMC will play a key role in supporting Mitsubishi Motors three-year DRIVE FOR GROWTH strategic plan. By 2019, Mitsubishi Motors aims to have further strengthened its operations across China by more than doubling the sales units as well as its dealer network, compared with 2016 levels. The company will also focus on expanding its vehicle lineup of four-wheel drive and PHEV SUVs in the country.

    (1) New Energy Vehicles in China are defined as full electric, plug-in hybrid or fuel cell vehicles
    (2) It can be purchased from after receiving the subsidy of NEVs

    About GAC Mitsubishi Motors (GMMC)

    Based in Changsha, Hunan, GMMC was formed as a joint venture company in 2012 between Guangzhou Automobile Group (50% ownership stake), Mitsubishi Motors Corporation (30% ownership stake) and Mitsubishi Corporation (20% ownership stake). GMMC has 4,100 employees, and serves as a sales and distribution platform for GAC and MMC-branded vehicles in China. The company has an annual production capacity over 270,000 units per year between the Mitsubishi Motors ASX and Outlander SUVs, as well as the GAC Eupheme and Eupheme EV GMMC maintains over 300 sales and service locations across China.

    About Mitsubishi Motors

    Mitsubishi Motors Corporation is a global automobile company based in Tokyo, Japan, which has a competitive edge in SUVs and pickup trucks, electric and plug-in hybrid electric vehicles. Since the Mitsubishi group produced its first car more than a century ago, we have demonstrated an ambitious and often disruptive approach, developing new vehicle genres and pioneering cutting-edge technologies. Deeply rooted in Mitsubishi Motors' DNA, our brand strategy will appeal to ambitious drivers, willing to challenge conventional wisdom and ready to embrace change. Consistent with this mindset, Mitsubishi Motors introduced its new brand strategy in 2017, expressed in its "Drive your Ambition" tagline - a combination of personal drive and forward attitude, and a reflection of the constant dialogue between the brand and its customers. Today Mitsubishi Motors is committed to continuous investment in innovative new technologies, attractive design and product development, bringing exciting and authentic new vehicles to customers around the world.

    Contact:
    Mitsubishi Motors Public Relations Department http://www.mitsubishi-motors.com +81-3-6852-4275

    Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com

    0 0

    TOKYO, Oct 16, 2018 - (JCN Newswire) - Mitsubishi Motors Corporation (MMC) has announced two major milestones in the expansion of its China business. GAC Mitsubishi Motors (GMMC), the joint venture business in China between the MMC, the Guangzhou Automobile Group (GAC) and Mitsubishi Corporation has begun production of 4B4 and 4J1 engines, and also held a groundbreaking ceremony for the Research and Development Center which will be completed in 2020.

    The new engine plant has an annual production capacity of 200,000 units (standard operating base). It will produce the new 1.5L direct-injection turbocharged gasoline engine (4B4 engine) with high environmental performance which will be fitted to the Eclipse Cross SUV. In addition, the plant will make the 4J1 engine for the locally-produced Outlander SUV.

    Producing the engines locally will enhance cost competitiveness and further strengthen market position in the world's largest automotive market. In addition to increasing employment at the new factory, the production will result in more jobs in the supply chain.

    Mitsubishi Motors will launch the Eclipse Cross on the market this fall to expand its product lineup and strengthen its SUV brand and support the local sales network.

    GMMC has also agreed with Changsha City to expand and relocate to a newly established R & D center with a site area of 41 hectares, including a test course. The center will further strengthen GMMC's technological development functions to meet the local market needs for China.

    About GAC Mitsubishi Motors (GMMC)

    Based in Changsha, Hunan, GMMC was formed as a joint venture company in 2012 between Guangzhou Automobile Group (50% ownership stake), Mitsubishi Motors Corporation (30% ownership stake) and Mitsubishi Corporation (20% ownership stake). GMMC has 4,100 employees, and serves as a sales and distribution platform for GAC and MMC-branded vehicles in China. The company has an annual production capacity over 270,000 units per year between the Mitsubishi Motors ASX and Outlander SUVs, as well as the GAC Eupheme and Eupheme EV GMMC maintains over 300 sales and service locations across China.

    About Mitsubishi Motors

    Mitsubishi Motors Corporation is a global automobile company based in Tokyo, Japan, which has a competitive edge in SUVs and pickup trucks, electric and plug-in hybrid electric vehicles. Since the Mitsubishi group produced its first car more than a century ago, we have demonstrated an ambitious and often disruptive approach, developing new vehicle genres and pioneering cutting-edge technologies. Deeply rooted in Mitsubishi Motors' DNA, our brand strategy will appeal to ambitious drivers, willing to challenge conventional wisdom and ready to embrace change. Consistent with this mindset, Mitsubishi Motors introduced its new brand strategy in 2017, expressed in its "Drive your Ambition" tagline - a combination of personal drive and forward attitude, and a reflection of the constant dialogue between the brand and its customers. Today Mitsubishi Motors is committed to continuous investment in innovative new technologies, attractive design and product development, bringing exciting and authentic new vehicles to customers around the world.

    Contact:
    Mitsubishi Motors Public Relations Department http://www.mitsubishi-motors.com +81-3-6852-4275

    Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com

    0 0

    TOKYO, Oct 16, 2018 - (JCN Newswire) - Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries(1) in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.

    Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for development and sales in each country.

    Lorcaserin is a novel chemical entity that is believed to decrease food consumption and promote satiety by selectively activating serotonin 2C receptors in the brain. Lorcaserin was approved in 2012 by the U.S. Food and Drug Administration (FDA) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related co-morbid condition, and was launched in the United States in June 2013. Lorcaserin was approved in Mexico and Brazil with the same indication as for the United States in July 2016 and December 2016, respectively.

    By entering into this agreement with Eurofarma, which has a strong business foundation throughout the region, Eisai aims to continue its effort to make lorcaserin widely available to appropriate patients as soon as possible.

    (1) 17 countries: Argentina, Belize, Bolivia, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela

    About lorcaserin hydrochloride (product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin")

    Discovered and developed by Arena Pharmaceuticals, Inc., lorcaserin is a novel chemical entity that is believed to decrease food consumption and promote satiety by selectively activating serotonin 2C receptors in the brain. Activation of these receptors may help a person eat less and feel full after eating smaller amounts of food. Lorcaserin was approved in June 2012 by the U.S. Food and Drug Administration (FDA) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related co-morbid condition, and was launched in the United States under the brand name BELVIQ in June 2013 after receiving a final scheduling designation from the U.S. Drug Enforcement Administration (DEA). In addition, lorcaserin has been made available in South Korea via a third-party distributor from 2015. Lorcaserin was approved in Mexico in July 2016 and in Brazil in December 2016, with the same indication as for the United States. Furthermore, BELVIQ XR, a once-daily formulation of lorcaserin aiming to increase convenience of administration for patients, was approved in the United States in July 2016. In January 2017, Eisai acquired all of Arena's rights to develop and market lorcaserin.

    In August 2018, in a cardiovascular outcomes trial (CAMELLIA-TIMI61) of lorcaserin, a post-marketing clinical trial evaluating safety as the primary objective, it was confirmed that lorcaserin did not increase the incidence of major adverse cardiovascular events (MACE: defined as cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) compared to placebo, and the primary safety objective was met. Regarding the primary efficacy endpoint of incidence of MACE+ (consisting of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, hospitalization due to unstable angina, heart failure or coronary revascularization), statistical non-inferiority compared to placebo was confirmed for lorcaserin. Data on the effect of lorcaserin on prevention and remission of type-2 diabetes mellitus was announced in October 2018.

    The most common adverse reactions observed in multiple Phase III clinical studies on lorcaserin were headache, dizziness, fatigue, nausea, dry mouth and constipation in patients without diabetes, and hypoglycemia, headache, back pain, cough and fatigue in patients with diabetes.

    About Worldwide Overweight and Obesity (Eisai's internal estimates)

    In recent years, obesity has become a major global health problem, with more than 1.4 billion adults worldwide believed to be overweight (BMI of 25 kg/m2 or greater) and approximately 500 million of that number qualifying as obese (BMI of 30 kg/m2 or greater). By region, around 170 million people in the United States and 150 million people in Europe are reported to fall into one or both categories, while in Asia, the overweight and obese population includes an estimated 100 million people in China and a further 25 million people in Japan.

    In Latin America as well, obesity is becoming a serious health issue, with approximately 125 million patients diagnosed with obesity. Due to changes in lifestyle and other factors, the incidence of obesity is expected to increase from approximately 20% at present to approximately 30% by 2024.

    About Eurofarma Laboratorios S.A. (Eurofarma)

    Founded in 1972, Eurofarma is one of the largest pharmaceutical companies in Brazil and is present in 20 countries in South and Central America, the Caribbean and Africa. In addition to Brazil, it has its own operations in Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Paraguay, Peru and Uruguay, and also sells products in Belize, Costa Rica, Dominican Republic, El Salvador, Honduras, Mexico, Nicaragua, Panama, Venezuela and Mozambique. Eurofarma's capabilities span from research and development to clinical trial execution to marketing and sales of in-licensed and wholly owned products. Eurofarma's mission is to promote access to health and quality of life with reasonably priced treatments while maintaining a profitable operation to assure sustainable growth and share the value generated with employees and society. To learn more about Eurofarma, please visit www.eurofarma.com.br.

    About Eisai

    Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our human health care philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Oncology and Neurology.

    As a global pharmaceutical company, our mission extends to patients around the world through our investment and participation in partnership-based initiatives to improve access to medicines in developing and emerging countries.

    For more information about Eisai Co., Ltd., please visit www.eisai.com.

    Contact:
    Public Relations Department, Eisai Co., Ltd. +81-(0)3-3817-5120

    Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com

    0 0

    CLEVELAND, Ohio, Oct 16, 2018 - (ACN Newswire) - The Lubrizol Corporation announces the commercial availability of Carboset(R) CR-3100 acrylic copolymer emulsion. Carboset CR-3100 is designed to offer protective properties and adhesion to metal substrates in low VOC formulations.

    Carboset CR-3100 is a water-borne, styrene-acrylic emulsion that is excellent for direct-to-metal coatings. With outstanding adhesion to a variety of metal surfaces and superb chemical and corrosion resistance, this polymer offers impressive performance with a single coat in light and medium-duty industrial applications. Carboset CR-3100 can be formulated to a range of glosses for great aesthetics in a finish that lasts.

    "Carboset CR-3100 has the functional flexibility to perform in a variety of environments," shares Nick Sterne, market manager, Lubrizol Performance Coatings. "In addition to providing great performance in low VOC formulations, this resin is APEO and formaldehyde-free to comply with strict regulations. Carboset CR-3100's performance as a single coat system can also enable more efficient application for end users."

    Visit lubrizol.com/coatings for additional information about Carboset CR-3100 and other advanced coating technologies from Lubrizol.

    About Lubrizol Performance Coatings

    Lubrizol is a market-driven innovator of specialty chemicals that solve today's challenges in the paints and coatings, printing and packaging, paper and textiles, plastics and composites, and digital print markets. More than just a supplier, we are a collaborator with extensive experience in surface protection, dispersion, adhesion, filtration and barrier properties that enables us to enhance the performance, simplicity, and sustainability benefits of our customers' products. With a commitment to collaboration, applied science, and demonstrated value, our team of experts is dedicated to exceeding customer expectations for both the simplest and toughest requirements. Count on Lubrizol to make the difference.

    About The Lubrizol Corporation

    The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It is a leader at combining market insights with chemistry and application capabilities to deliver valuable solutions to customers in the global transportation, industrial and consumer markets. Lubrizol improves lives by acting as an essential partner in our customers' success, delivering efficiency, reliability or wellness to their end users. Technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care, personal care and skin care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions.

    With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 8,700 employees worldwide. Revenues for 2017 were $6.3 billion. For more information, visit Lubrizol.com.

    Media Contact
    Mike Heil
    216-447-5176
    Website: www.lubrizol.com

    ###

    This announcement is distributed by West Corporation on behalf of West Corporation clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: Lubrizol via Globenewswire

     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    HONG KONG, Oct 16, 2018 - (ACN Newswire) - The board of directors (the "Board") of Green Leader Holdings Group Limited (the "Company", together with its subsidiaries, the "Group", HKEx Stock code: 61) announces clarification of inaccurate contents contained in certain media articles (the "Articles"), which in relation to the arrest warrant issued by Cambodia to two senior management of the Company and the progress of the group's cultivation.

    The Company entered into of an acquisition agreement by a subsidiary of the Group with six obligors as announced on 31 March 2017. One of the obligors had commercial disputes with the Group and made false accusation by way of a criminal complaint in Cambodia against Mr. Zhang Sanhuo ("Mr. Zhang"), the Chairman and an executive director of the Company, and Mr. Tse Michael Nam ("Mr. Tse"), the Chief Executive Officer and an executive director of the Company, alleging forgery on their part. Both Mr. Zhang and Mr. Tse immediately upon learning the arrest warrant had engaged Cambodia legal adviser to commence legal action to cancel the arrest warrant and defend the criminal complaint. The arrest warrant had subsequently been cancelled on 29 November 2017. The Cambodia legal adviser had also applied on behalf of Mr. Zhang and Mr. Tse to dismiss the criminal complaint and the criminal complaint had been dismissed on 28 December 2017. Mr. Zhang and Mr. Tse consider such criminal complaint and false accusations were vexatious or frivolous with an aim to assert undue pressure on the Group and its directors and this was later proved by the dismissal of the criminal complaint.

    The Articles also gave groundless allegation that the Group had only completed the cultivation of less than 500 hectares of cassava in Cambodia in 2018. As disclosed in the 2017 annual report and 2018 interim report of the Company, the Group had completed the cultivation of 2,500 hectares of cassava.

    The Company reserves all its rights to pursue in respect of such inaccurate contents in the Articles.

    About Green Leader Holdings Group Limited (Stock code: 61)
    Green Leader Holdings Group Limited and its subsidiaries principally engaged in (i) the development of processing and production of bio-energy ethanol, cassava starch/ modified starch products using cassava as raw material; and (ii) coal exploration and development (mining operation) and the provision of coal trading and logistics services.


     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    Long-term efficacy and safety evaluation in patients with insomnia, a sleep-wake disorder, met primary and key secondary efficacy objectives

    TOKYO, Oct 17, 2018 - (JCN Newswire) - Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy and safety evaluation of lemborexant, an investigational agent for sleep-wake regulation currently being studied for the potential treatment of multiple sleep-wake disorders. Topline results reported today are the primary and key secondary outcomes of the study from the six-month, placebo-controlled treatment period; the study is ongoing to 12 months. Eisai and Purdue Pharma plan to present full results from SUNRISE 2 at upcoming medical meetings in 2019.

    SUNRISE 2 enrolled more than 900 adult patients (18 to 88 years of age) with insomnia disorder, characterized by difficulty falling asleep and/or staying asleep. The study met the pre-specified primary and key secondary efficacy objectives assessed by patient self-reports (sleep diaries). At the end of the six-month, placebo-controlled treatment period, lemborexant 5 mg and 10 mg provided statistically significant improvement in subjective sleep onset latency compared to placebo, the study's primary endpoint. Lemborexant 5 mg and 10 mg also provided statistically significant improvement in sleep maintenance variables of subjective sleep efficiency and subjective wake after sleep onset compared to placebo, which were the study's key secondary endpoints. Daily functioning, as measured by the Insomnia Severity Index, was also improved by both lemborexant 5 mg and 10 mg compared to placebo. Overall discontinuation rates due to AEs were comparable between placebo and lemborexant 5 mg, and higher for lemborexant 10 mg.

    "As a clinician and researcher treating patients with insomnia and other sleep-wake disorders for 30 years, for me, successful treatment means that patients fall asleep fast, sleep well, and wake well, without functional impairment, or loss of effect over time," said Russell Rosenberg, PhD, D.ABSM, a Principal Investigator in the lemborexant studies and former Chairman of the Board of the National Sleep Foundation. "The results of SUNRISE 2 are particularly encouraging for the many patients who suffer from chronic insomnia."

    The results of SUNRISE 2 build on a growing body of knowledge supporting the development of lemborexant, including SUNRISE 1, a zolpidem tartrate extended release as well as key safety studies evaluating for impairment as assessed by the ability to maintain postural stability - a predictor of risk for falls - after middle-of-the-night and next morning awakening and next-morning driving performance.

    "Our aspiration for lemborexant is to bring to the millions of patients suffering from insomnia and other sleep- wake disorders an agent for sleep-wake regulation that improves their ability to fall asleep and stay asleep, and maintains efficacy over time," said Lynn Kramer, MD, Chief Clinical Officer and Chief Medical Officer, Neurology Business Group, Eisai. "In SUNRISE 2, lemborexant improved time to sleep onset and sleep maintenance over a six-month period. With these results, we now look forward to proceeding with regulatory submissions for lemborexant to bring to patients a long-term treatment option for treating the sleep-wake disorder, insomnia."

    Lemborexant appears to impact the underlying reason for a patient's inability to sleep well. Lemborexant acts on the orexin neurotransmitter system and is believed to regulate sleep and wake by dampening wakefulness without impeding the ability to awaken to external stimuli.
    "These lemborexant study results for sleep onset and sleep maintenance are critical parts of the sleep-wake paradigm for those suffering from insomnia," said Marcelo Bigal, MD, PhD, Chief Medical Officer, Purdue Pharma. "We understand the importance of sleep-wake regulation to overall health and patient outcomes and, alongside our collaboration partner, Eisai, look forward to continued research as part of our commitment to a variety of patient populations with sleep-wake disorders."

    Discovered by Eisai, lemborexant is being jointly developed by Eisai and Purdue Pharma. Information about ongoing clinical studies is available at clinicaltrials.gov.

    This release discusses investigational uses of an agent in development and is not intended to convey conclusions about efficacy or safety. There is no guarantee that such investigational agent will successfully complete clinical development or gain health authority approval.

    About Lemborexant

    Lemborexant, an investigational dual orexin receptor antagonist, is Eisai's in-house discovered and developed small molecule compound which inhibits orexin neurotransmission, or signaling, by binding competitively to two subtypes of orexin receptors (orexin receptor 1 and 2). In individuals with sleep-wake disorders, it is possible that the orexin system which regulates wakefulness is not functioning normally. During normal periods of sleep, orexin system activity is suppressed, suggesting it is possible to purposefully counteract inappropriate wakefulness and facilitate the initiation and maintenance of sleep.

    Eisai and Purdue Pharma are investigating lemborexant as a potential treatment option for insomnia and other sleep-wake disorders. A Phase 2 clinical study of lemborexant in patients with irregular sleep-wake rhythm disorder and mild to moderate Alzheimer's dementia is underway.

    About SUNRISE 2 / Study 303(1)

    A 12-month multicenter, global, randomized, controlled, double-blind, parallel group study of 971 male or female adult participants (18 to 88 years of age) with insomnia disorder, including a screening and two-week placebo run-in period, a 52-week treatment period and a two-week follow- up period. All patients received lemborexant for at least six months during the study. Lemborexant 5 mg, 10 mg or matching placebo was taken orally in tablet form at home each night immediately before the patient intended to try to sleep for the first six months of study. The primary outcome measure was mean change from baseline in subjective sleep onset latency after six months of placebo-controlled treatment. Key secondary outcome measures were mean change from baseline in subjective sleep efficiency and subjective wake after sleep onset after six months of placebo- controlled treatment.

    About Sleep Disorders

    Population studies show that sleep disorders affect many more people worldwide than previously thought.(2) Insomnia disorder is characterized by difficulty falling sleep, staying asleep or both,
    despite an adequate opportunity to sleep, that can lead to daytime consequences such as fatigue, difficulty concentrating and irritability.(3),(4) Insomnia disorder is the most common sleep disorder, with persistent insomnia symptoms experienced by approximately 10 percent of the adult population.(2),(3)

    Sleeping well is essential for good health, including brain health. Poor sleep is associated with a wide range of health consequences, including an increased risk of hypertension, accidental injury, diabetes, obesity, depression, heart attack, stroke and dementia, as well as adverse effects on mood and behavior.(4),(5)

    Experimental studies in animals and humans provide evidence of associations between sleep and disease risk factors, diseases and mortality.(2),(6) Studies suggest an optimal sleep duration between seven and eight hours.(2),(6) Women are 1.4 times more likely than men to suffer from insomnia.(7) Older adults also have higher prevalence of insomnia; aging is often accompanied by changes in sleep patterns, including disrupted sleep, frequent waking and early waking, that can lead to less sleep time.(8)

    About Purdue Pharma L.P.

    Purdue Pharma L.P. develops and provides prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. We were founded by physicians and we are currently led by a physician. Beyond our efforts to provide quality medications, Purdue is committed to supportingnational, regional and local collaborations to drive innovations in patient care. Privately held, Purdue is pursuing a pipeline of new medications and technologies through internal research & development and strategic industry partnerships. For more information, please visit www.purduepharma.com.

    (1) Eisai Inc. Long-term study of lemborexant in insomnia disorder (E2006-G000-303).
    (2) Ferrie JE, et al. Sleep epidemiology - a rapidly growing field. Int J Epidemiol. 2011;40(6):1431-1437.
    (3) Ohayon MM, et al. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97-111.
    (4) Institute of Medicine. Sleep disorders and sleep deprivation: An unmet public health problem. Washington, DC: National Academies Press. 2006.
    (5) Pase MP, Himali JJ, Grima NA, et al. Sleep architecture and the risk of incident dementia in the community. Neurology. 2017;89(12):1244-1250.
    (6) Trenell MI, et al. Sleep and metabolic control: waking to a problem? Clin Exp Pharmacol Physiol. 2007;34:1-9.
    (7) Zhang B, Wing, YK. Sex differences in insomnia: a meta-analysis. Sleep. 2006;29(1):85-93.
    (8) Ohayon MM, et al. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27:1255-1273.

    About Eisai

    Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our human health care philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Oncology and Neurology.

    As a global pharmaceutical company, our mission extends to patients around the world through our investment and participation in partnership-based initiatives to improve access to medicines in developing and emerging countries.

    For more information about Eisai Co., Ltd., please visit www.eisai.com.

    Contact:
    Public Relations Department, Eisai Co., Ltd. +81-3-3817-5120

    Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com

    0 0

    TAIPEI, TAIWAN, Oct 17, 2018 - (ACN Newswire) - MEDICAL TAIWAN, which focuses on medical, health, and care, is taking place June 27-30, 2019 at the TWTC Exhibition Hall 1 in Taiwan.

    The event organizer the Taiwan External Trade Development Council (TAITRA), has integrated two shows, MEDICARE and SenCARE, to create a new show, MEDICAL TAIWAN, which combines three fields - Medical, Health and Care - to create the only B2B business platform in the medical device and healthcare industry in Taiwan.

    The growth of the aging population has translated into greater demand for medical treatment and care services. Industry insiders are therefore pursuing more efficient medical care solutions, in order to reduce medical costs. The three topics at MEDICAL TAIWAN will synchronize the trends of health management, precision medicine and long-term care, and reveal the advantages of Taiwanese medical supply chains.

    MEDStartup Village Showcases the Innovations that are Shaping Future Digital Healthcare Trends.

    Artificial intelligence (AI), big data analytics, and the Internet of Things (IoT) will dominate future medical developments. Companies in both the ICT and traditional industries are cooperating with the aim of embracing infinite opportunities. With its strong drive in the precision-machine and ICT industries, Taiwan is keeping an eye on this market.

    MEDStartup Village was established to enable startups to showcase their ideas and get funding to substantiate their products, as well as provide a space for companies to network and shape the future of digital healthcare.

    Abundant Business Opportunities for Professionals in the Medical Industry

    The previous event attracted 5,286 local and international industry visitors from China, Japan, Malaysia, Hong Kong, Vietnam, the Philippines, USA, South Korea, Thailand, and Singapore. 290 one-on-one procurement meetings took place, double the number of the year prior.

    MEDICAL TAIWAN booths are open for registration October 22. Book your space to seize infinite business opportunities in Asia. For more information, please visit our official website: www.medicaltaiwan.com.tw

    About TAITRA

    Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwan businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets.

    Contact
    Kevin Chang
    MedicalTaiwan@taitra.org.tw

     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    HKTDC Hong Kong Electronics Fair (Autumn Edition) and electronicAsia attracted close to 87,000 buyers from 139 countries and regions during the four-day fair period.
    Nicolas Yang, Secretary for Innovation and Technology of the Hong Kong Special Administrative Region, visits the fair and exchanges views with start-ups, learning more about the latest innovations from Hong Kong companies.
    The Tech Hall at the Autumn Electronics Fair features high-tech thematic zones including Startup, Virtual Reality, Robotics & Unmanned Tech, Smart Tech and 3D Printing.
    Industry Survey Shows Chinese Mainland, Middle East & ASEAN as Most Promising Emerging Markets

    HONG KONG, Oct 16, 2018 - (ACN Newswire) - The 38th HKTDC Hong Kong Electronics Fair (Autumn Edition) and the 22nd electronicAsia concluded today, attracting close to 87,000 buyers from 139 countries and regions over a four-day period. Buyer attendance grew from a number of countries and regions including mature markets such as Canada, Italy, Singapore, Taiwan and the UK, and emerging markets such as Brazil, the Chinese mainland, India, Indonesia, Malaysia and Russia. More than 63,500 buyers visited the Autumn Electronics Fair while over 23,400 visitors attended electronicAsia. The Electronics Fair was organised by the Hong Kong Trade Development Council (HKTDC), while electronicAsia was jointly organised by the HKTDC and MMI Asia.

    HKTDC Deputy Executive Director Benjamin Chau said: "In the face of global economic uncertainty, Hong Kong companies are pushing to strengthen R&D and develop new technologies in a bid to launch innovative electronic products. At the two fairs, we saw how they are successfully applying advanced technologies such as artificial intelligence (AI) and augmented reality (AR) to a wide range of electronic products, attracting the attention of global buyers. Thematic zones at the fairs, such as the Tech Hall and Hall of Fame, helped to meet the needs of the industry while a series of events at the Autumn Electronics Fair helped to introduce the products and technologies of start-up companies to potential buyers, partners, investors and the media, assisting them to capture new business opportunities."

    The HKTDC commissioned an independent survey during the fair period, interviewing a total of 1,043 exhibitors and buyers on the outlook for the electronics market and new product trends. Some 60% of respondents said the recent Sino-US trade friction has had a negative effect on their export performance. Around 40% of respondents said they expect their company's overall sales to grow this year - 13 percentage points lower than the proportion that gave the same response in 2017. In terms of markets with growth prospects, survey respondents view Japan as the most promising traditional market (75%), followed by South Korea (73%) and Western Europe (72%), while the Chinese mainland (77%), Middle East (76%) and ASEAN countries (76%) are seen to have the best prospects among emerging markets.

    In terms of product trends, the survey reveals that audio-visual products (17%) have the most growth potential in 2019, followed by electronic/electrical accessories (14%) and digital imaging (9%). For AR and virtual reality (VR) devices, almost 80% of respondents are optimistic about the market development in the next two years, while most respondents think that mobile and online games (57%) and audio-visual entertainment devices (45%) have the largest market potential. For robotics applications, 67% of respondents say they are optimistic about market developments in the next two years, with entertainment purposes such as toy robots (40%) having the largest market potential, followed by home applications such as vacuum cleaners (36%) and medical applications such as rehabilitation treatments (24%).

    Spotlighting AI and Other Innovations

    The Tech Hall at the Electronics Fair featured five thematic zones, including Robotics & Unmanned Tech, Smart Tech, Virtual Reality, 3D Printing and Startup zones. First-time exhibitor Tuya Global showcased its AI solutions for smart home appliances and lighting products, hoping to expand its overseas markets. Morgan Fang, Business Development Manager of Tuya Global, said: "Many buyers want to upgrade their traditional products into smart products. We established connections with new buyers from Europe, North America and Southeast Asia during the fair and are now discussing cooperation plans."

    Taiwanese start-up exhibitor Serafim Technologies showcased a virtual laser projection keyboard that attracted a lot of attention from buyers. GZ Chen, CEO of the company, said they have met with new buyers from Hong Kong, the Chinese mainland, Southeast Asia, Germany, Italy and Russia, and have secured orders for a total of 5,000 sets. He said the business results from the fair were very encouraging.

    Under the theme "AI Empowerment - Grow without Limits", the Symposium on Innovation & Technology featured representatives from the Hong Kong Applied Science and Technology Research Institute (ASTRI), Cisco, Deloitte, IBM, Microsoft, Pfizer and SenseTime. They discussed how AI can empower organisations and affect the employment picture, as well as some of the challenges associated with AI implementation. The symposium attracted more than 1,260 participants.

    Buyers Place On-the-spot Orders

    Australian buyer Jaka Exstrada took part in the Autumn Electronics Fair for the first time. He identified six potential suppliers of advanced driver-assistance systems and breathalysers through the HKTDC business matching service, and plans to buy a container of products from each supplier after the fair. He has also placed an order with an existing supplier from the Chinese mainland for air quality products worth US$200,000.

    At electronicAsia, Malaysian buyer CH Ooi placed an order worth up to US$60,000 for liquid-crystal displays (LCDs) and measurement instruments. He said that talks were also underway with several new suppliers from the Chinese mainland for GPS-related tracking devices, including sensors and cameras, and the potential orders could be valued up to US$200,000.

    For more comments from exhibitors and buyers, please visit https://bit.ly/2Ci1qkm and https://bit.ly/2PCGmZs

    Fair Website
    Hong Kong Electronics Fair (Autumn Edition): http://hkelectronicsfairae.hktdc.com
    electronicAsia: www.electronicasia.com
    Photo Download: https://bit.ly/2IYISGV

    About HKTDC

    The Hong Kong Trade Development Council (HKTDC) is the dedicated to creating opportunities for Hong Kong's businesses. With more than 40 offices globally, including 13 on the Chinese mainland, HKTDC promotes Hong Kong as a platform for doing business with China, Asia and the world. HKTDC organises international exhibitions, conferences and business missions to provide companies, particularly SMEs, with business opportunities on the mainland and in international markets, while providing business insights and information via trade publications, research reports and digital channels including the media room. Please visit www.hktdc.com/aboutus or follow us on Google+, Twitter@hktdc, LinkedIn.

    Contact:
    Sunny Ng, Tel: +852 2584 4357, Email: sunny.sl.ng@hktdc.org Joshua Cheng, Tel: +852 2584 4395, Email: joshua.cp.cheng@hktdc.org

    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    Leading Attribution Company Reaches New Milestones Amid Evolving Mobile Marketing Landscape

    SAN FRANCISCO, Oct 17, 2018 - (ACN Newswire) - AppsFlyer, the global leader in mobile attribution and marketing analytics, announced today that it surpassed $100 million in Annual Recurring Revenue (ARR) in the third quarter of 2018, growing at 100% every 12 months. Driving the company's revenue growth are the 85,000 apps whose marketers use AppsFlyer's products and services, propelling the company to over 70% market share worldwide.

    "As a customer-obsessed company, our mission is to empower clients to achieve their goals by building best-in-class technology and products," said Oren Kaniel, CEO and co-founder of AppsFlyer. "We are excited to offer a product that is the primary working tool for mobile marketers. As more businesses continue recognizing that an attribution platform is a mission-critical tool, I'm humbled that more top brands, agencies and developers than ever trust AppsFlyer to help them make better marketing decisions, protect their ad spend from fraud, and fuel their own data-driven marketing innovations."

    The company's revenue figures follow a string of recent plaudits for the company and considerable growth across key benchmarks. In the past year, AppsFlyer has continued to form partnerships with many prominent brands, including eBay, NBCUniversal, Adidas, Hyundai, Coca Cola, Times Internet, Grab and ByteDance. AppsFlyer's technology is now found on nearly 7 billion mobile devices, up from 4.5 billion devices at the same time last year. During Q3 2018, AppsFlyer's media spend measured increased to $17 billion annually, an 89 percent jump from $9 billion last year. At the same time, AppsFlyer's continued innovation of anti-fraud solutions resulted in significantly higher savings for marketing departments using AppsFlyer's technology - blocking an estimated $6.5 million a day of ad fraud.

    "Thanks to our extensive investment in the AppsFlyer product and service, I'm proud that 70% of the market selected AppsFlyer," said Kaniel. "We like to believe that our superior reliability, pace of innovation, service -- and the AppsFlyer experience as a whole played a major role in the selection process. There are no shortcuts here. Hard work leads to consistent results, which manifests in achieving this milestone. Measurement is a crucial component of any budgetary decision, and companies are taking the time to select the best product that suits their needs. Inaccurate data and fraud cause companies to face serious challenges with their media spend -- costing them millions of dollars without necessarily being aware of the damage it's causing until it's too late. Our scale and market share allow us to provide unique offerings -- such as unparalleled attribution accuracy and fraud prevention -- by leveraging the trillion-plus mobile events we measure every month.".

    Goldman Sachs identified Kaniel as one of the "100 Most Intriguing Entrepreneurs" of 2018, and AppsFlyer was named the Hottest Marketing Technology Startup of 2018 at the Europas. The number of employees at the company has doubled from 230 last year to 465, in 15 offices around the world.

    About AppsFlyer

    AppsFlyer's technology is found on 98 percent of the world's smartphones, making it the global leader in mobile attribution and marketing analytics. Data-driven marketers rely on AppsFlyer for independent measurement solutions and innovative tools to grow and protect their mobile business. AppsFlyer's platform processes billions of mobile actions every day, empowering app marketers and developers to maximize the return on their marketing investments. AppsFlyer's NativeTrack(TM) Attribution, Marketing Analytics Data, OneLink's Deep linking capabilities and the Active Fraud Suite featuring DeviceRank have made AppsFlyer's platform the go-to resource for the most successful mobile apps in the world. With Facebook, Google, Twitter, Pinterest, Snap Inc., Tencent and 4,000+ other integrated partners, and clients including HBO, Playtika, Waze, Alibaba, Kayak, Activision and 12,000+ leading brands worldwide, AppsFlyer has 15 global offices to support marketers everywhere. To learn more, visit www.appsflyer.com.

    Media Contact:
    Jill Burkes
    jill@headline.media
    +1 917 722 5054

    Press release (PDF): http://www.acnnewswire.com/clientreports/598/AppsFlyer_1810.pdf

     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

    0 0

    Companies to use artificial intelligence to deliver financial advice in tune with the lifestyles of bank customers in Japan

    TOKYO, Oct 17, 2018 - (JCN Newswire) - Fujitsu Limited, Blue Lab Co., Ltd., and Personetics Technologies Ltd. have begun a joint proof of concept (PoC) trial of Personetics Engage(1), an AI-powered solution for the delivery of personalized financial advice to bank customers. The PoC trial is performed in collaboration with Moneytree K.K.(2) The purpose of the trial is to test the benefits delivered by Personetics Engage and how well its AI-powered insights and recommendations fit with the needs of banking customers. From October 17, 2018, an estimated 300 people, mainly employees from Blue Lab and Fujitsu, will use Personetics Engage from a customer's point of view. Fujitsu, Blue Lab, and Personetics will then measure and evaluate the precision and degree of customer satisfaction they have in the solution. Personetics Engage has been implemented by over 20 major banks in the US and Europe, and is currently used by some 50 million digital banking users. By combining various types of AI, the solution utilizes financial industry know-how to deliver personalized, accurate and timely financial advice in tune with the daily lifestyles of users such as their financial behavioral patterns, which includes optimized recommendations, and predictions of cash flow and financial assets(3). Based on the trial's results, Fujitsu, Blue Lab, and Personetics aim to build a full-fledged business to provide personalized banking services that can be used by a range of Japanese financial institutions.

    Background

    In recent years, the point of interface between financial institutions and their users has continued to shift from face-to-face to digital channels. Financial institutions are strengthening their relationships with customers by proactively engaging them with useful information and advice delivered through digital channels rather than waiting for customers to physically visit the institutions, which was once regarded as the prerequisite. For this reason, satisfaction in financial services can be expected to improve through digital channels by providing important information and relevant financial advice with easy-to-understand guidance to each individual customer.

    Overview

    In the PoC trial, Fujitsu, BlueLab, and Personetics will monitor the cash flow of test subjects' account information, scheduled and actual records of deposit/withdrawal, and credit card details by integrating Personetics Engage with existing data of Japanese financial institutions and Moneytree's permission-based data sharing platform, Moneytree LINK, in order to deliver appropriate recommendations for each test subject.

    1. PoC trial period

    October 17, 2018 - February 28, 2019 (Scheduled)

    2. Objective

    Utilizing existing data held by Japanese financial institutions, the objective of the PoC trial is to measure the effects of deploying the service to the Japanese market with regard to the alerts, advice and other insights generated by Personetics Engage, which has been widely implemented by European and US banks.

    3. Target

    Mainly Blue Lab and Fujitsu Employees (300 people in total)

    4. Roles

    PoC trial data provider: Blue Lab
    PoC environment provider: Personetics
    PoC data and environment execution: Fujitsu
    PoC trial evaluation: Blue Lab, Personetics, Fujitsu

    5. Validation Objectives

    - Measure the number of alerts and insights that can be created
    - Evaluate the feasibility and compatibility of insights content to Japanese financial services
    - Evaluate user engagement and usage of the insights
    - Evaluate data compatibility with an eye toward deployment and official service introduction, and to clarify operational methods

    Future Plans

    The parties will work together to develop an AI-powered recommendation service that can provide timely financial advice and emit cash flow alerts through a digital channel to customers in Japan. In this way, the companies aim to build a new personalized banking services business for financial institutions that customers in Japan will want to use.

    (1) Personetics Engage Cognitive personalized recommendation solution.
    (2) Moneytree K.K. HQ: Minato,Tokyo; CEO: Paul Chapman. The company provides a financial data portability platform, comprised of a personal financial management app, Moneytree, and a permission-based API feed of customer data for financial institutions, Moneytree LINK.
    (3) Personal Financial Assets Cash, deposit, stock, security, insurance, pension, periodic warranty, mutual fund etc.

    About Blue Lab Co., Ltd.

    HQ: Minato, Tokyo; CEO: Daisuke Yamada. Blue Lab explores not only into financial industry but also into various other industries and sectors to promote production and commercialization of future business models by utilizing new technologies.

    About Personetics Technologies Ltd.

    HQ: Giv'atayim, Israel; CEO: David Sosna. An Israel-based start-up company established in 2010. Currently works with several leading banks worldwide and has over 50 million users.

    About Fujitsu Ltd

    Fujitsu is the leading Japanese information and communication technology (ICT) company, offering a full range of technology products, solutions, and services. Approximately 140,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE: 6702) reported consolidated revenues of 4.1 trillion yen (US $39 billion) for the fiscal year ended March 31, 2018. For more information, please see http://www.fujitsu.com.

    * Please see this press release: http://www.fujitsu.com/global/about/resources/news/press-releases/

    Contact:
    Fujitsu Limited Public and Investor Relations Tel: +81-3-3215-5259 URL: www.fujitsu.com/global/news/contacts/

    Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com

    0 0

    TOKYO, Oct 17, 2018 - (JCN Newswire) - NEC Corporation (TSE: 6701) today announced a strategic collaboration with Arm Limited (Arm) to drive the development of secure Internet of Things (IoT) solutions for Smart Cities using artificial intelligence (AI).

    There is already a wide range of IoT connected devices in the market today and the selection will continue to rapidly grow. Ensuring the security of these devices is a top priority that poses a major challenge for many companies.

    As part of addressing these issues, NEC will adopt the Arm Platform Security Architecture (PSA)(1), an industry standard framework for building securely connected devices, which includes the concept of threat modeling, architectural guidelines and implementation resources that reduce the cost, complexity, and risk associated with IoT security.

    NEC has an accomplished history of enhancing the security of products, systems and services while contributing to the safety and security of customers in many different fields. NEC's innovative IoT security technologies(2) are consistent with the spectrum of mitigation approaches that the PSA framework encompasses.

    "The pace of deployment of IoT devices is growing rapidly, and Smart Cities will be an important use case for AI-enabled IoT," said Chet Babla, vice president solutions, IoT Device IP, Arm. "Ensuring that IoT devices are secure is non-negotiable, and why Arm is working with partners such as NEC to shift the economics of security by providing the common framework that PSA enables."

    NEC is also slated to unveil the development of a box-type accelerator(3), a specialized device featuring real-time facial recognition that will be securely managed and provisioned by Arm Pelion Device Management.

    This accelerator will be equipped with the Arm Cortex-A53 processor. It will accelerate the device's facial recognition process and enable faster analytics by offloading the analytics workload carried out on servers or the cloud, thereby helping to reduce costs for networks and systems.

    NEC's facial recognition technology is ranked as the world's most accurate and fastest by the U.S. National Institute of Standards and Technology (NIST) benchmark tests(4). NEC has already implemented over 700 biometric systems, including face recognition technologies in more than 70 countries and regions throughout the world.

    "We expect the new accelerator to promote further adoption of face recognition throughout many areas, including the public safety, entertainment and transportation fields, as it contributes to the security and convenience of consumers worldwide," said Naoki Hashitani, SVP, NEC Corporation.

    NEC has already begun developing a Smart City project leveraging Arm technology in the resort town of Shirahama in western Japan. NEC aims to begin a proof of concept hospitality project with Smart Check-In and Smart Shopping features in December 2018. These services are expected to enable visitors to check-in to hotel rooms and make cashless payments through the use of facial authentication. The project includes facial recognition with the new accelerator and is expected to be a reference model for expansion into a wide range of new areas.

    "We aim to revitalize the regional economy leveraging IoT technologies and look forward to collaborating with NEC to drive the digital transformation that will help create new business for the Shirahama area," said Shin Okada, president and CEO, NankiShirahama Airport, Inc.

    (1) Arm Platform Security Architecture (PSA):
    https://pages.arm.com/psa-resources.html
    (2) Press Release: NEC develops tamper detection technology to protect IoT devices
    https://www.nec.com/en/press/201804/global_20180402_01.html
    (3) Commercial sales are expected to launch in the first half of 2019
    (4) Press Release: NEC's Video Face Recognition Technology Ranks First in NIST Testing
    https://www.nec.com/en/press/201703/global_20170316_01.html

    About NEC Corporation

    NEC Corporation is a leader in the integration of IT and network technologies that benefit businesses and people around the world. The NEC Group globally provides "Solutions for Society" that promote the safety, security efficiency and fairness of society. Under the company's corporate message of "Orchestrating a brighter world," NEC aims to help solve a wide range of challenging issues and to create new social value for the changing world of tomorrow. For more information, visit NEC at https://www.nec.com.

    Contact:
    NEC Seiichiro Toda s-toda@cj.jp.nec.com +81-3-3798-6511

    Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com

    0 0

    Meeke to join Tanak and Latvala in driving the Yaris WRC

    Toyota City, Japan, Oct 17, 2018 - (JCN Newswire) - TOYOTA GAZOO Racing World Rally Team is pleased to confirm its driver line-up for the 2019 FIA World Rally Championship season, when it will again enter three Toyota Yaris WRC models on every event.

    Ott Tanak will continue to drive the Toyota Yaris WRC next year alongside co-driver Martin Jarveoja after joining the team of the 2018 season, during which they have already won on four occasions and are challenging for the drivers' championship.

    Jari-Matti Latvala will also stay with the team. The experienced Latvala and co-driver Miikka Anttila have been a key part of the team since its debut in Monte Carlo in January 2017. They scored the first podium of Toyota's WRC return on the very same event, and the first victory just a few weeks later in Sweden. Latvala has achieved four podiums so far this year, including three in the last four rounds.

    Joining Tanak and Latvala in the line-up for 2019 will be Kris Meeke. The Northern Irishman is recognised as one of the quickest drivers in the WRC, claiming five rally wins since 2015. Meeke, whose co-driver will be confirmed at a later date, will join TOYOTA GAZOO Racing World Rally Team to form a fast and experienced driver line-up.

    Esapekka Lappi and co-driver Janne Ferm will leave the team following the conclusion of the 2018 season. The pair made their debut in the top category of the WRC with Toyota on Rally Portugal last year, and soon scored their maiden victory at Rally Finland. This season they have taken three podium finishes so far, contributing to the team's current position in the lead of the manufacturers' championship. TOYOTA GAZOO Racing World Rally Team would like to thank Esapekka and Janne for their hard work.

    Akio Toyoda (Team Chairman)

    "To Esapekka Lappi and Janne Ferm: Thank you for battling together with us as part of our team over the last two years. Your victory at last season's Rally Finland was outstanding. We were all truly impressed. With your youthful exuberance, Esapekka, you have provided the team with immense motivation. At this year's Rally Finland, I was able to witness first-hand how much you value your fans, and how much you are loved by them. I am full of gratitude to you for strengthening TOYOTA GAZOO Racing's bond with its supporters.

    Co-driver Janne, you were always joking, lightening the mood, and energizing our team. If I hear hearty laughter coming from a rival team's tent at WRC rallies next year, it will be reassuring to know that both you and Esapekka--our former partners--are flourishing.

    I have no doubt that next season Esapekka and Janne will again make us stronger--this time as our rivals. It excites me to think that we will once again have an opportunity to energize the WRC together. Until then, however, let us make sure we fight for this year's championship to the very end! TOYOTA GAZOO Racing will continue with its efforts to create ever-better cars so that, until the very last stage of the very last rally, both of you will be able to demonstrate your full potential.

    Finally, to Kris Meeke, who will join our team from next season: I have great hopes that with your vast experience you will help make the Yaris WRC even better. When you first step into the Yaris WRC, please let us know what you think. Under the leadership of Team Principal Tommi Makinen, we will ensure the Yaris WRC can be driven with even greater peace of mind. I trust you will look forward to the start of next season with great excitement."

    Tommi Makinen (Team Principal)

    "We are all very excited to have Kris joining us here at TOYOTA GAZOO Racing. We know that he is very fast, but he also brings a lot of experience. His technical understanding is at a really high level and I believe he can provide new knowledge and ideas to help us in our aim to keep making the Yaris WRC better.

    I am also very pleased that Jari-Matti will continue to be part of our team. He has done some brilliant work for us and has recently been regularly on the podium again, which has been very important. Together with Ott, who has proven that he is absolutely one of the fastest drivers right now, I think we have a very strong line-up for next year, with three drivers who are all quick, experienced and can win rallies. I believe we will again have a strong team to fight for both the drivers' and manufacturers' titles.

    Lastly, I am very sorry to see that Esapekka has decided to leave us for a new challenge, but we all wish him the best of luck for the future."

    Kris Meeke

    "It's a huge pleasure and honour for me to become a Toyota driver. I'd like to thank Akio Toyoda, Tommi Makinen and the entire Toyota team for their faith in me. Three years ago, we first discussed the possibility of me joining the team, and I'm so happy that it's finally happened now.

    The performance of the Yaris WRC speaks for itself, but the team spirit here is incredible at every level, also with the Japanese culture of honour and respect. I can't wait to get started. I've got no particular objectives other than to enjoy my driving again and help Toyota to win a championship.

    The very first championship that I won was actually when I was aged 16 and co-driving for my brother on our local road rally championship. We clinched that title in a Toyota Corolla, so for very many reasons, it feels incredibly good to be here. I can't think of a better place to be."

    About Kris Meeke
    Date of birth: July 2, 1979
    Age: 39 years old
    Nationality: British

    Highlights
    2005: 3rd overall, FIA Junior WRC
    2009: Intercontinental Rally Challenge champion, 4 wins
    2014: First WRC podium, Rallye Monte-Carlo
    2015: First WRC win, Rally Argentina
    2016: Wins Rally Portugal and Rally Finland
    2017: Wins Rally Mexico and Rally Spain

    WRC Statistics
    WRC starts 91, Victories 5, Podiums 12, Points scored 413, Stage Wins 77

    About Toyota Motor Corporation

    Toyota Motor Corporation (TMC) is the global mobility company that introduced the Prius hybrid-electric car in 1997 and the first mass-produced fuel cell sedan, Mirai, in 2014. Headquartered in Toyota City, Japan, Toyota has been making cars since 1937. Today, Toyota proudly employs 370,000 employees in communities around the world. Together, they build around 10 million vehicles per year in 29 countries, from mainstream cars and premium vehicles to mini-vehicles and commercial trucks, and sell them in more than 170 countries under the brands Toyota, Lexus, Daihatsu and Hino. For more information, please visit www.toyota-global.com.

    Contact:
    Public Affairs Division Global Communications Department Toyota Motor Corporation Tel: +81-3-3817-9926

    Copyright 2018 JCN Newswire. All rights reserved. www.jcnnewswire.com

    0 0

    HONG KONG, Oct 17, 2018 - (ACN Newswire) - Ethfinex, the token trading platform, and Blockpass, a data-secure user identity and compliance solution, are set to revolutionise the way people invest in ICOs with the announcement of a partnership today. Through this partnership, traders using the Ethfinex platform will be able to create a user-centric verified identity profile that can be used to allow instantaneous access to participation in ICOs on Ethfinex.

    Blockpass is a digital identity application and service that brings control of data back to the user. Blockpass provides a streamlined and cost-effective user onboarding process for regulated industries and any kind of online service. From the Blockpass application, users can create, store and manage their data-secure digital identity, which can be used to access an entire ecosystem of services or for token purchase.

    Ethfinex seeks to provide direct access to pre-vetted token sales for users in an environment that mitigates some of the risks associated with existing ICO contribution methods. A spin-off of Bitfinex, Ethfinex offers a hybrid trading solution for token trading, where users can face the liquid order books of Bitfinex and Ethfinex, but without surrendering control of their digital assets or funds. Ethfinex offers the best of all worlds - high speed, liquid trading without compromising on security or privacy.

    Through the partnership, Blockpass will be integrated into Ethfinex, allowing registered users of Ethfinex to download the Blockpass app, complete KYC and submit this to Ethfinex by scanning a QR code. Once a profile is approved, and meets the requirements of Ethfinex, the user will be able to participate in any number of ICOs provided on the Ethfinex platform without having to go through the KYC process again.

    The two parties are also discussing opportunities to further improve and streamline the trading process through collaboration in other mutually beneficial areas.

    Ethfinex Commercial Director, Ross Middleton commented: "We are very excited to be working with Blockpass and to integrate their user-centric KYC service into our token sale offering. Blockpass gives our users an easy and quick way of managing their personal KYC data, whilst at the same time allowing us to manage the approval process for different token sales and token issuers in a secure and compliant manner."

    Blockpass CEO, Adam Vaziri commented: "We are delighted to be able to announce our partnership with Ethfinex. Blockpass is designed to help users deal with the inefficient and tedious process of complying with KYC, whilst also providing a user-centric and regulatory compliant solution. Through our partnership with Ethfinex, we see Blockpass helping a great many people to safely take back control of their data, and we can remove some of the pain-points involved with investing in promising ICO projects."

    About Blockpass IDN
    The goal of Blockpass IDN (http://www.blockpass.org/) is global realization of identity for the Internet of Everything. Through the use of blockchain technology and smart contracts, Blockpass is a production ready Regtech platform offering shared regulatory and compliance services for humans, businesses, objects and devices. As this identity system supports verification of humans (KYC), objects (KYO) and connected devices (KYD), it will enable the development of new applications that rely on a trusted connection between human, corporate, and device identities. Registered in Hong Kong, Blockpass IDN is a joint venture of Infinity Blockchain Labs and Chain of Things. Blockpass IDN licenses its technology from the non-profit Blockpass Foundation, registered in the Isle of Man.

    For more information and updates, please visit and sign up to the following:
    Promotional video: https://youtu.be/SvO2cw3e-SI
    Website: http://www.blockpass.org
    Medium: https://medium.com/@blockpass
    Twitter: https://twitter.com/BlockpassOrg
    Facebook: https://www.facebook.com/blockpassorg/
    Telegram: https://t.me/blockpass

    Media contact: Caitlin Betts, +852 9733 4935, press@blockpass.org.

     
    Copyright 2018 ACN Newswire. All rights reserved. www.acnnewswire.com

older | 1 | .... | 301 | 302 | (Page 303) | 304 | 305 | .... | 320 | newer